 NANPING, China, June 25, 2021 PRNewswire -- Happiness Biotech Group Limited the Company or Nasdaq: HAPP, an innovative China-based nutraceutical and dietary supplements producer, announced today that it has entered into a securities purchase agreement with certain non-U.S. strategic investors for a registered direct placement of approximately 2.16 million, pursuant to which the Company agreed to sell 1.24 million ordinary shares at a per share purchase price of 1.74, 7.4 premium to the closing price of June 24, 2021. Happiness Biotech intends to use the gross proceeds in the development of the Companys auto business under the brand of Taochejun and for working capital and general corporate purposes. 